Johnson & Johnson (JNJ) reported its Q3 2026 financial results on October 13, 2026, before market open. The company posted earnings per share of 2.59 USD, beating the analyst estimate of 2.52 USD by 2.7%. Reported revenue stood at 25,399 million USD. Following the release, the stock price reacted with a decline of 5.73%.
Generated automatically from our data — as of October 15, 2026
Key figures at a glance
Estimate (EPS): 2.52 USD
Reported (EPS): 2.59 USD
Price reaction: -5.7%
Frequently asked questions
Did Johnson & Johnson beat or miss earnings-per-share expectations?
Johnson & Johnson beat the analyst estimate of 2.52 USD earnings per share (Q3 2026) by 2.7%, reporting 2.59 USD.
How did Johnson & Johnson stock react to the earnings report?
Johnson & Johnson stock fell 5.7% on the trading day following the release.
What was Johnson & Johnson's revenue in Q3 2026?
Johnson & Johnson reported revenue of 25,399M USD in Q3 2026.